Meghan Markle and Prince Harry's Hollywood plans might be on hold. According to sources, their Netflix film projects haven't shown any clear progress since March. However, another source claimed that this is standard practice in the industry. Meanwhile, their production company has reportedly lost another executive.
Sources told Page Six that the Sussexes' Netflix films, "Meet Me at the Lake" and "The Wedding Date," remain in development. The first is based on Carley Fortune's bestselling book. It has reportedly been in development since August 2023, and it's believed to have an attached director whose identity remains under wraps. "The Wedding Date," based on Jasmine Guillory's novel, has been in development since 2025.
However, a second source called it simply how Hollywood works. "Things are not made in a day," the industry insider said. They explained that adaptations take a while, especially as producers work with the book writers on the script.
The couple's untitled scripted polo drama also hasn't received any update. Harry is reportedly working on a documentary about Princess Diana ahead of her 30th death anniversary. Netflix's potential involvement in the film currently remains unclear.
Meanwhile, Archewell Productions' longtime head of nonfiction, Chanel Pysnik, is reportedly leaving. She helmed the Netflix documentary "Harry & Meghan." Page Six was told that she wanted a "new chapter." Following her exit, Nishika ******* ble, senior vice president of scripted television, remains a key executive in the company. The outlet reported last month that Archewell Productions was downsizing.

#netflix #reportedly #development

AA Milne's first Pooh book was published a century ago in October 1926. Generations of children loved it, but its inspiration, the author's own son, told the BBC that he took to "running away when people bring up the subject".
"Pooh, promise you won't forget about me, ever. Not even when I'm a hundred." This is the plaintive cry made by Christopher Robin to his teddy bear, Winnie-the-Pooh, in the final chapter of The House in Pooh Corner.
British novelist and playwright AA Milne needn't have worried. The first Winnie-the-Book was published 100 years ago in October 1926, and introduced a cast of characters modelled on the author's son and the soft toys he played with: lovably dim Pooh Bear, nervy Piglet, hyperactive Tigger, pessimistic Eeyore. Far from being forgotten, in the century since then the characters have taken on a life far beyond the parameters of their idyllic home, the Hundred Acre Wood.
BBC Radio 4, Desert Island Discs: Christopher Milne, 13/11/1976
From 1966, they became the subject of animated and live-action Disney films, in what is now one of the highest-grossing media franchises of all time. Pooh Bear has even courted controversy in Poland for being "inappropriate", sparked memes mocking the Chinese president Xi Jinping, and prompted tongue-in-cheek pop-culture theories in which the residents of the Hundred Acre Wood have been "diagnosed" with different psychological conditions.

#christopher #acre #wood

The under-15 Meninos da Vila beat Ituano 2-1 in the first leg of the Campeonato Paulista round of 16 at Estádio Novelli Júnior this Saturday (17), taking the lead in the tie as they chase a place in the quarterfinals! Kléber opened the scoring in the first half, and Dudu scored the winner in stoppage time!
Next Saturday, the teams meet again at CT Rei Pelé at 9 a.m. to decide who advances to the next round.
The under-17 side lost 3-2 to Sfera at CT Rei Pelé in the first leg of the state championship round of 16. Vinicius Rocha and Maylon scored Santos' goals.
The teams will also meet again next Saturday at CFA Jarinu at 11 a.m.
This article was translated into English by Artificial Intelligence. You can read the original version in 🇧🇷 here.

#meninos

Wim Wenders has boarded "Truth:Beauty," a feature documentary about legendary German fashion photographer Peter Lindbergh, as executive producer.
The project, produced by Maja Hoffmann and Human Humans, will mark the feature directorial debut of French novelist Alexandra Matine, whose books include "Scopophilia" and "La Pire Amie du monde."
More from Variety
'From Inside Out - The Architecture of Peter Zumthor' Review: Wim Wenders' Latest 3D Documentary Is an Architectural Marvel
Wim Wenders Clarifies His Stance on Filmmakers' Role in Politics After Berlin Controversy: 'We Are the Opposite of Politicians ... We Are the Antidote'

#peter #german #maja #hoffmann

Arnold Schwarzenegger is teaming up with James Patterson.
The actor and former governor of California co-wrote an upcoming book ******* led The Protector with Patterson, one of the world's most widely read authors. This marks Schwarzenegger's debut as a novelist. It will be published by Little, Brown and Company on Oct. 4, 2027.
The new novel is set in modern-day Los Angeles. It follows a Catholic priest named Father Viktor Brennan, a military veteran who is new to a small parish plagued by violence.
"Father Brennan confronts the criminals threatening the community he's vowed to protect, even as his courageous actions endanger his life, and reveal clues to his mysterious past," according to an official description.
The character of Father Viktor Brennan takes inspiration from both Schwarzenegger and Patterson's Catholic backgrounds.

#father #brennan #james

Jeffrey Archer said he was feeling "wistful and nostalgic" about his upbringing in Somerset a week before his death.
The bestselling author and former politician, who grew up in Weston-super-Mare, died on Monday at the age of 86, the day before the release of his latest - and last - novel.
BBC Breakfast presenter Jon Kay interviewed Archer last week at his alma mater, Wellington School in Somerset. He said Archer had been reflecting on his "extraordinary life" during their conversation.
"He admitted he was feeling a little wistful and nostalgic, reminiscent about Somerset in his later years," Kay said.
Author and former politician Jeffrey Archer dies aged 86

#somerset #feeling #week

By Sam Tobin
LONDON, Oct 5 (Reuters) - Jeffrey Archer, the bestselling British novelist and former politician who was jailed for lying in a high-profile libel case, died aged 86 on Monday, just one day before his final novel "Adam and Eve" was due to be published.
The confidant of ‌former prime minister Margaret Thatcher lived a life that swung from the heights of luxury and fame to the lows of a two-year stint in ‌prison for perjury over paying a woman for **** .
He sold more than 300 million copies of his books, spent a total of five and a half years on the New York Times bestseller lists and found fans around the world with his pacy thrillers, among them the 1976 debut "Not a Penny More, Not a Penny Less" and 1979's mass-selling "Kane & Abel".
Publisher HarperCollins said Archer, who had met and signed books for fans in London's Leicester Square Theatre on Sunday and had been scheduled to speak at events this week, died "suddenly and peacefully at home ... between writing sessions".

#books #fans

Bestselling British author and scandal-plagued Conservative politician Jeffrey Archer has died aged 86.
Archer died "suddenly and peacefully" at his home yesterday, a day before the global release of his final novel, "Adam and Eve," publisher HarperCollins said.
The new book out today, like his bestselling novel "Kane and Abel," follows a pair of biblically named characters born on the same day to different social classes. "Kane and Abel", released in 1979, remains one of the best-selling novels in the world, with an estimated 34 million copies sold globally.
Kate Elton, HarperCollins UK CEO and Archer's editor, said: "It has been one of the great privileges of my publishing life to have been Jeffrey Archer's editor. He was the master storyteller and an editor's dream - phenomenally hard-working, utterly committed to completing draft after draft to get every word as perfect as possible, and a true champion of the 'team' nature of great publishing."
Archer sold more than 300 million books in his five-decade writing career, including "Not A Penny More, Not A Penny Less", the William Warwick series, and the Clifton Chronicles, which started with 2011's "Only Time Will Tell" and spanned seven novels up until 2016's "This Was A Man".

#archer #died

Jeffrey Archer has died aged 86, just one day before the publication of his final novel, Adam & Eve.
The bestselling author and former Conservative politician died at home on Monday, October 5, his publisher HarperCollins confirmed. The announcement described his death as occurring "suddenly and peacefully at his home between writing sessions".
The news comes shortly after Jeffrey met readers at a sold-out London event, where he discussed the book and signed copies.
He leaves behind his wife, Dame Mary Archer, their two sons and five grandchildren. The couple celebrated their 60th wedding anniversary earlier this year.
Jeffrey died just a day before the release of his final novel (@ Instagram)

#final #adam #october

British author Jeffrey Archer, who penned a series of best-selling novels, served as a Conservative MP and was convicted of perjury, died suddenly at 86, his publisher HarperCollins said.
Archer died "suddenly and peacefully at his home between writing sessions" on Monday, HarperCollins said.
His editor, Kate Elton, called him a "master storyteller and an editor's dream".
The writer had been due to appear at Cheltenham Literary Festival this week to discuss "Adam and Eve", what he described as his final novel after 50 years of storytelling.
It was due to be published Tuesday.

#archer #british #jeffrey

Jeffrey Archer, the prolific British author and former politician, has died at the age of 86.
Archer's publisher HarperCollins confirmed his death in a statement, revealing that the Kane & Abel writer died "suddenly and peacefully at home" on Monday. A cause of death was not disclosed.
More from Deadline
Jeffrey Archer & 'Black Warrant' Maker Applause Entertainment To Adapt Six Bestellers For Film & TV
'Tinder Swindler' Indie Hire; Jeffrey Archer Novel TV Adaptation; Movistar Plus+/Banijay Scripted Deal - Global Briefs

#died #british #kane

LONDON, Oct 5 (Reuters) - Jeffrey Archer, the best-selling British novelist and former ‌politician who was jailed for lying ‌in a high-profile libel case, has died aged 86, his publisher HarperCollins said on Monday.
Archer sold over 300 million copies worldwide and was known for pacy thrillers like his ‌1976 debut "Not ⁠a Penny More, Not a Penny Less" and "Kane & Abel", with his ⁠final novel Adam and Eve due to be published this month.
He was also a prominent Conservative politician, who briefly served as a ‌lawmaker before becoming a senior party official under prime minister Margaret Thatcher in the mid-1980s.
But Archer suffered a very public downfall when he was convicted of ‌perjury and perverting the course of justice in 2001, being sentenced to four years' imprisonment.
Kate Elton, ‌HarperCollins' UK CEO and Archer's editor, said in a statement: "We're all devastated to have lost a writer who has brought ‌joy to generations of readers - and a true friend."

#archer #harpercollins #london #jeffrey

Nestled between two mountain ranges at the crook of central California's coastline sits a valley known as the "salad bowl of the world".
Farm workers stoop over neatly lined rows of crops off Highway 101 to harvest more than half of the nation's supply of lettuce and nearly a third of its strawberries. The soil here is so rich that author John Steinbeck made the Salinas valley the promised land in his literary depictions of people chasing the American dream: immigrants, farm workers, westward-moving hopefuls, hungering for a better life.
It's a story that continues to capture the American imagination: Netflix has adapted Steinbeck's 1952 blockbuster novel, East of Eden, into a limited series starring Florence Pugh, released 1 October.
"This will be a valley of great richness one day," Steinbeck wrote of the farmland in East of Eden. "And happy people will live here, thousands and thousands."
But Steinbeck also understood just how difficult it can be to achieve that elusive American dream. Even after some his characters found their way to Salinas and other parts of California's agricultural valley, many remained stuck in low-paying jobs, making barely enough to scrape by, let alone own their own land.

#american #workers

BioNTech SE (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 trial in patients with metastatic squamous non-small cell lung cancer whose disease had progressed after prior immunotherapy and chemotherapy. Reuters said gotistobart nearly doubled survival compared with standard-of-care chemotherapy, strengthening the case for the drug as a potential chemotherapy-free treatment in a population with significant unmet need.
The result builds on earlier Stage 1 data, where gotistobart reduced the risk of death by 54% versus docetaxel, with a hazard ratio of 0.46. Median overall survival was not yet reached for gotistobart versus 9.95 months for docetaxel, while the 12-month progression-free survival rate was 25.2% versus 0%. BioNTech is now awaiting the pivotal Stage 2 readout, making the latest result important not only for the drug's approval prospects but also for the credibility of BioNTech's broader transition from a COVID-vaccine company toward a multi-product oncology business.
The strongest bullish argument is that gotistobart now has repeated evidence of a meaningful survival advantage in a difficult-to-treat lung-cancer population. The earlier Stage 1 dataset showed 55.6% of patients alive in the gotistobart arm versus 23.8% with docetaxel, alongside a 54% reduction in the risk of death. The latest Phase 3 update reinforces that signal rather than introducing an entirely new hypothesis. If the pivotal Stage 2 data confirm the benefit, BioNTech SE (NASDAQ:BNTX) could have a differentiated therapy capable of competing on survival rather than simply response rates, potentially supporting meaningful pricing power and a commercially attractive oncology franchise.
The result also strengthens BioNTech's broader oncology strategy because gotistobart is one piece of a much larger pipeline rather than a standalone bet. BioNTech says it has 14 ongoing pivotal trials and more than 10 novel combination programs, while its lung-cancer strategy spans more than 16 ongoing clinical trials and five Phase 3 programs. Gotistobart's success therefore provides validation for the company's immuno-oncology capabilities, while other ****** ets such as pumitamig and antibody-drug conjugates advance toward additional indications. BioNTech has identified 17+ late-stage or pivotal readouts through 2030+, creating the possibility that a successful gotistobart launch becomes the first major commercial proof point in its planned transition to a multi-product oncology company.

#stage #survival

BioNTech SE (NASDAQ:BNTX) reported that its investigational lung-cancer drug gotistobart produced a clinically meaningful overall-survival benefit in the Phase 3 PRESERVE-003 trial in patients with metastatic squamous non-small cell lung cancer whose disease had progressed after prior immunotherapy and chemotherapy. Reuters said gotistobart nearly doubled survival compared with standard-of-care chemotherapy, strengthening the case for the drug as a potential chemotherapy-free treatment in a population with significant unmet need.
The result builds on earlier Stage 1 data, where gotistobart reduced the risk of death by 54% versus docetaxel, with a hazard ratio of 0.46. Median overall survival was not yet reached for gotistobart versus 9.95 months for docetaxel, while the 12-month progression-free survival rate was 25.2% versus 0%. BioNTech is now awaiting the pivotal Stage 2 readout, making the latest result important not only for the drug's approval prospects but also for the credibility of BioNTech's broader transition from a COVID-vaccine company toward a multi-product oncology business.
The strongest bullish argument is that gotistobart now has repeated evidence of a meaningful survival advantage in a difficult-to-treat lung-cancer population. The earlier Stage 1 dataset showed 55.6% of patients alive in the gotistobart arm versus 23.8% with docetaxel, alongside a 54% reduction in the risk of death. The latest Phase 3 update reinforces that signal rather than introducing an entirely new hypothesis. If the pivotal Stage 2 data confirm the benefit, BioNTech SE (NASDAQ:BNTX) could have a differentiated therapy capable of competing on survival rather than simply response rates, potentially supporting meaningful pricing power and a commercially attractive oncology franchise.
The result also strengthens BioNTech's broader oncology strategy because gotistobart is one piece of a much larger pipeline rather than a standalone bet. BioNTech says it has 14 ongoing pivotal trials and more than 10 novel combination programs, while its lung-cancer strategy spans more than 16 ongoing clinical trials and five Phase 3 programs. Gotistobart's success therefore provides validation for the company's immuno-oncology capabilities, while other ***** ets such as pumitamig and antibody-drug conjugates advance toward additional indications. BioNTech has identified 17+ late-stage or pivotal readouts through 2030+, creating the possibility that a successful gotistobart launch becomes the first major commercial proof point in its planned transition to a multi-product oncology company.

#biontech #survival

By Tom Hals
WILMINGTON, Delaware, Sept 15 (Reuters) - As U.S. President Donald Trump seeks to crack down on what he says is widespread illegal voting by noncitizens, several people charged with that crime are trying a novel strategy to get their cases dropped.
Five people being prosecuted in separate federal cases in Miami and Madison, Wisconsin, have ‌argued for the first time in court that the 1996 law used to charge them is unconstitutional, according to a Reuters review of court filings.
A ruling for the ‌defendants, which could come before the November 3 midterm elections, would raise questions about the federal government's authority to prosecute noncitizen voting cases. The Trump administration has pushed to deport noncitizen voters, raising the stakes for defendants who previously faced as little as a $150 fine if convicted.
The defendants were accused of violating the federal "Voting by Aliens" statute enacted three decades ago. The law makes it illegal for noncitizens to vote in federal elections, and violators can be fined up to $100,000 or imprisoned for up to a year.

#cases #people

By Brad Brooks
COLUMBIA FALLS, Montana, Sept 16 (Reuters) - More than 15 years after the U.S. Supreme Court reshaped American politics with its Citizens United campaign finance ruling, Montana voters will decide this November whether to make their state the first in the nation to bar corporations from spending money on elections through a ballot initiative.
It's a test case for a novel legal strategy that sidesteps the 2010 ruling rather than challenging it head-on -- and taps into growing, bipartisan anger ‌over the pervasiveness of so-called dark money in elections.
"Americans are losing the belief that they have any influence over our politics," said Tom Moore, a lawyer with the Center for American Progress left-leaning think tank in Washington and the legal architect of ‌the movement.
With similar, coordinated efforts underway in over 30 states, Montana could help set a critical precedent, experts say, and potentially lead to another showdown at the Supreme Court. Hawaii's legislature passed a similar law earlier this year, inspired by those behind the effort here.

#court #similar

Parnassus Investments, an investment management company, released the "Parnassus Growth Equity Fund" second-quarter 2026 investor letter. The letter can be downloaded here. During the quarter, the Fund (Investor Shares) returned 17.49% (net of fees), outperforming the Russell 1000 Growth Index's 16.74%. Holdings in Information Technology and Consumer Discretionary sectors boosted relative returns, while Communication Services and Financials holdings detracted. For the year-to-date period, the Fund returned 6.17% (net of fees), outperforming the Russell 1000 Growth's 5.33%. The firm remains constructively bullish on U.S. equities and continues to be selective, valuation-sensitive, and focused on disruptive growth opportunities through active stock selection. Growth stocks advanced during the second quarter, as the Russell 1000 Growth Index generated strong double-digit returns driven by increased confidence in the durability of the ongoing artificial intelligence (AI) infrastructure build-out. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Parnassus Growth Equity Fund highlighted Revolution Medicines, Inc. (NASDAQ:RVMD) as a new addition. Revolution Medicines, Inc. (NASDAQ:RVMD) is a clinical-stage precision oncology company that develops novel targeted therapies for RAS-addicted cancers. On September 15, 2026, Revolution Medicines, Inc. (NASDAQ:RVMD) closed at $204.86 per share. Over the past month, Revolution Medicines, Inc. (NASDAQ:RVMD) declined 6.53% and its shares gained 358.00% over the past 52 weeks. Revolution Medicines, Inc. (NASDAQ:RVMD) has a market capitalization of $43.91 billion.
Parnassus Growth Equity Fund stated the following regarding Revolution Medicines, Inc. (NASDAQ:RVMD) in its Q2 2026 investor letter:
"In the Health Care sector, we see compelling long-term idiosyncratic growth opportunities in drug discovery, diagnostics and medical innovation. During the quarter, we added Revolution Medicines, Inc. (NASDAQ:RVMD), developer of a promising new drug for pancreatic cancer. Revolution Medicines' lead drug candidate, daraxonrasib, has delivered strong late-stage clinical results in pancreatic cancer, with data suggesting it could become a new standard of care and support significant commercial potential, alongside additional opportunities in other cancers over time."
Revolution Medicines, Inc. (NASDAQ:RVMD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 105 hedge fund portfolios held Revolution Medicines, Inc. (NASDAQ:RVMD) at the end of the second quarter, compared to 106 in the previous quarter. While we acknowledge the potential of Revolution Medicines, Inc. (NASDAQ:RVMD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Tr

What's been exciting about Robinhood Chain (RHC) is seeing tokens attempt new mechanisms to answer questions like: why would someone hold this token? How can we make participating in this token attractive? And, more broadly, how can market activity around a token overall be designed to contribute to its success?
All new projects should ask this and the best ones do, but when you have a new chain, with a new market and new infrastructure, it can be sort of a "clean slate" or fresh design ***** e and breathe new life into the solutions to such questions.
The dominant answer right now seems to be distributions: hold this token and get stock, tokens, etc. Below are projects which execute this with a twist, expanding either the type of rewards or the source for rewards that end up in the hands of holders.
Others attempt to answer the second question, experimenting with new infrastructure that tries to make market activity, of whatever kind, directly contribute to the token's success.
These are all shared to give you a sense of what novelty can look like amidst this meta and act as a guiding force to understand what's been done, what's working, and overall where to direct your attention towards.

#make

Art imitates life imitates...
In summer 2026, word started to spread that the movie star at the center of Rachel Cusk's new novel, Life of M, appeared to draw heavily from the life and career of Natalie Portman, who had previously met Cusk, praised her writing, and promoted her work through her book club. While Cusk has resisted confirming the connection and Portman herself has not publicly addressed it, sources close to the actress have denied that she had any involvement in the book. Life of M is hardly the first time a seemingly fictional character has closely resembled a real-world figure.
Still, as Cusk recently put it to The New York Times, while skirting the question of M's real-life parallels: "Famous people enter the public imagination... it is part of fame's deal, and part of its tragedy."
Here are nine instances in which a celebrity has seen themselves reflected in a fictional character — and weighed in. Many of them didn't bother holding back.
Anna Wintour at the 2025 Met Gala; Meryl Streep in 'The Devil Wears Prada'
Credit: Theo Wargo/FilmMagic; 20th Century Fox

#real

For Texas volleyball, playing at Moody Center Sunday isn't about a novelty anymore.
It's about getting a desperately needed win and a modicum of momentum entering SEC play.
UP NEXT
NO. 9 TEXAS VS. NO. 6 WISCONSIN
When/where:

#texas #center #novelty

Hailey Bieber and Justin Bieber cuddled up in the PDA-filled debut issue of WYouth, a print publication aimed at the next generation of teens, and shared the films, songs and novels that they return to.
The images, taken by the Biebers on a Contax point-and-shoot camera, feature the couple mid-makeout, a shirtless Justin Bieber sleeping under the sheets and a close-up of the two canoodling in bed.
The Rhode beauty founder revealed Queen's "Bohemian Rhapsody" as her go-to karaoke song, with Justin Bieber name-dropping "With You" by Chris Brown. Fans will remember the "Baby" singer's rendition of the R&B song from a 2008 YouTube video, which has garnered more than 65 million views.
The couple also detailed their favorite films and books. The "Everything Hallelujah" singer picked "The Grinch" and the Bible, whereas Hailey Bieber named the Jennifer Aniston and Vince Vaughn-led rom-com "The Break-Up" and the children's book series "Angelina Ballerina," which she loved growing up, as her favorites.
Hailey and Justin Bieber also described their favorite ways to relax (the spa), favorite cities (a split between New York and Los Angeles) and favorite holidays (Thanksgiving and Christmas). They both agreed that picking an all-time favorite artist was simply "too hard."

#song

I'll never forget the first time I encountered Grindr. In 2009, I was enjoying happy hour at Cobalt, a since-shuttered gay bar in D.C.'s Dupont Circle. My friend, spying the mustard skull on an iPhone (first released in 2007!) from across the room, nudged me. "That's the gay hookup app," he whispered scandalously.
When I got over the stigma of downloading Grindr, I was astounded how easy it was to flirt with nearby queer men — and to network. During RuPaul's Drag Race season 3, I changed my username to "Team Jujubee," a nod to a frontrunner, which helped me find a viewing-party friend in my neighborhood. When I lived in New York, I would sometimes engage in friendly chats with the app's gay founder, Joel Simkhai, who'd pop up on my grid from time to time.
For good and ill, tech and our relationship with it has changed a lot since the aughts. Gay apps are no longer a battery-draining novelty; for many, they're as quotidian as texting, a digital town square where a Madonna takeover and catfishing are commonplace. Many, like Grindr, are also now owned by straight people. And no need to comb the upper reaches of Cablevision's channels to find Drag Race anymore — there's an app for that too (several, in fact, depending on the region and season).
This is Out's Tech Issue, and we could think of no better cover stars that encapsulate this queer new media landscape than Trixie Mattel and Katya Zamolodchikova. These queens went through the TV crucible of the House of Ru to emerge as stars of social media and the podcast world. (Their popular podcast, The Bald and the Beautiful, just signed a three-year deal with SiriusXM.) In their cover story on page 36, the media mavens discuss their dizzying rise through the digital spheres — and how their real-life friendship has kept them grounded.
Elsewhere in cyberspace, the advent of artificial intelligence has brought many miracles but also new terrors in how our data can be exploited. Learn how to protect yourself in the online dating world via Last Call (page 58). Technology does have its benefits; find ways it can improve your looks in our Beauty guide (page 26). But it's also important to find ways to unplug. In Out Picks, our editors highlight products that help them blissfully disconnect (page 8).

#time #drag #first

Natalie Portman is now a mom of three.
Portman, 45, welcomed her third baby, her first with partner Tanguy Destable, in Paris last month, according to People.
More from The Hollywood Reporter
How Natalie Portman Got Caught in Novelist Rachel Cusk's Autofiction Trap
Rachel Cusk's New Novel May Be Dark Portrait of Natalie Portman

#portman #tanguy

Well, there is something about first love. You don't forget it so easily, especially when the story begins with a suspenseful, romance-novel twist. That was certainly the case for social media star Alix Earle and New York Giants wide receiver Braxton Berrios. Earle originally sparked curiosity back in 2023 when she casually introduced him to her followers as the mysterious "NFL man" she was making sushi with. After nearly three years together, the fan-favorite couple officially called it quits last December.
As Earle decided to move on from that chapter of her life, she rented a big truck to move out of her ex-boyfriend's house two months after the breakup. With her best friend Sally in the passenger seat and Earle behind the wheel, the content creator discussed what went wrong between the couple.
"There's a ton of pressure that comes from, like, having a public relationship and sharing so much and people loving our relationship. But we were both busy in our careers and doing long distance at the time. We weren't talking as much. We were barely communicating. There was a lack of intimacy towards the end of the relationship, and it started to just, like, dwindle away a little bit,"Earle said on the first episode of reality series Earle Meets World, released on Friday on Netflix.
Earle and Berrios met at a Gatsby-themed party in Miami. A friend of Berrios approached Earle to tell her to talk to Berrios, so Earle walked up to Berrios, shoved her hand in his face, and asked, "You wanted to meet me?" The two eventually hit it off, but Earle had to leave the party early without saying goodbye to the WR.
Braxton Berrios keeps the drama going both on and off the field. Subscribe for more interesting stories.

#first #friend

After years as both an actor and a screenwriter, Cliff Dorfman is ready to set the stage for the next phase of his Hollywood career with his most personal project to date.
Dorfman, 58, rose to prominence in the 1990s with supporting roles on "Beverly Hills, 90210," among other shows. After shifting his focus to screenwriting, he wrote 14 episodes of HBO's "Entourage" and co-wrote the screenplay for the 2011 feature film "Warrior," starring Tom Hardy.
Buzz: Jameela Jamil Declares Botox A 'Prison' For Women: 'We Have Lost A Grip On Reality'
Despite those accomplishments, Dorfman says, he never had a chance to "understand my own story — and to survive it" until he wrote "Crime Family," his debut novel. Published in July, the 287-page thriller follows Chase Forman, a Hollywood writer who returns to his native Long Island, New York, to **** ist his family as his adoptive father's health and mental acuity decline.
Though Chase has spent most of his adulthood distancing himself from the Formans, he soon discovers that his family is part of an organized crime empire, with his adoptive mother, Helene, personally overseeing an international money-laundering operation. What follows is a gripping bicoastal chase as Chase and his family members become fugitives on the run from the FBI.

#family #dorfman #adoptive #cliff

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
The U.S. ETF industry is pushing back against the Securities and Exchange Commission's (SEC) broad review of "novel ETFs."
ETF professionals argue an overly wide definition could slow product launches and undermine one of the market's biggest advantages, even as increasingly complex funds test the boundaries of the traditional ETF structure, per a Reuters report.
The SEC opened the review in June after delaying a wave of proposed prediction-market ETFs. Its request covers ETFs that invest in innovative ***** et classes or use unconventional strategies and asks whether existing rules adequately address investor protection, market integrity, and the registration process.
More than 20 industry participants submitted comments around the Aug. 31 deadline, with the docket showing submissions from Charles Schwab, Franklin Templeton, Jane Street, Cboe Global Markets, Grayscale Investments, 21Shares, Andreessen Horowitz and Kalshi.

#industry #finance #securities #june

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
OpenAI revealed that its nascent advertising business has achieved a $1 billion annualized revenue run rate, a significant milestone reached within just 200 days of its inception.
The Sam Altman-led company **** ured on Monday that its ads are distinctly marked and do not affect ChatGPT's responses. Moreover, advertisers are not given access to users' private conversations, reported CNBC.
The advertising arm, which is barely 200 days old, supplements OpenAI's existing revenue channels, such as enterprise solutions, consumer subscriptions, and usage-based application programming interfaces.
In a press release, the company stated, "Our next phase of growth will bring ChatGPT Ads to more markets and introduce additional formats, objectives, buying options, and measurement capabilities." OpenAI also intends to explore novel ways for businesses to engage with consumers more organically within ChatGPT.

#within #benzinga #finance #altman

Two new working papers circulated by the authoritative National Bureau of Economic Research show the double squeeze the U.S. dollar and the Treasury market are facing both overseas and at home.
The first, from a team of European Central Bank and Banque de France economists, show how official demand for dollar ******* ets is waning as central banks increasingly seek sanctuary in gold after Russian ******* ets were frozen following the launch of the war on Ukraine in 2022. It's a topic that has certainly been discussed, but the paper quantifies that shift, finding nonaligned countries have moved nearly one-third of total reserve portfolios away from foreign-currency claims.
'It's not fair': My twin brother and I were left houses by our parents. Can I make him pay his share for taxes and upkeep?
'I feel tricked': My contractor handed my $42,000 pool upgrade to a subcontractor I had already rejected. What can I do?
Perhaps the more intriguing new paper comes from Massachusetts Institute of Technology economist Ricardo Caballero, who talks about a safe-debt Laffer Curve. The Laffer Curve represents the theory that, at a certain level, revenue actually starts to fall rather than rise as tax rates increase. Caballero's novel idea is that, at a certain level, federal debt actually hurts aggregate demand rather than helps it.

#curve #central #debt

It's reasonable to **** ume that people only really talk about Taylor Swift's outfits because she's Taylor Swift. But even beyond the hype, the Grammy winner has proven time and again that she possesses an impeccable fashion sense. The "Shake It Off" hitmaker knows how to cleverly build each public appearance to reward a closer look, whether it's the best outfits Swift has worn in every era of her career or a casual 2026 street style moment during which Swift perfectly nailed the '70s nostalgia look with only two items of clothing. On May 15, 2026, she and her then-fiancé Travis Kelce were photographed enjoying a night out on the town in Manhattan. The singer-songwriter was wearing some of the most expensive jewelry out there, but her dreamy ensemble was what stole the show.
Aeon/Getty
Understandably, what everybody noticed first was the dress — a gorgeous, cream-colored midi scattered with faded blue olive sprigs. Paired with beige, strappy leather sandals, the "I Knew You Were Trouble" hitmaker looked like she'd walked straight out of an Emily Brontë or Jane Austen novel. Swift's lipstick, the one colorful stroke in an otherwise neutral palette, is definitely worth a closer look, too. The pop star opted for a rosy shade, though not so bright as to look jarring against the rest of the outfit, which consisted mostly of muted florals. It complemented everything seamlessly, hammering home that prairie vibe she was going for. Being one of her last date-night looks as a bride-to-be before the July 3 ceremony, it offered yet another look into why Swift's story-rich aesthetic is one of a kind, and why we keep chasing the details well after the moment has passed.
Read more: Male Celebrities Who Were Unrecognizable After Plastic Surgery
Aeon/Getty Images

#hitmaker